Search Results

Site Search

Managing patient expectations for home specimen collection - Insights

When patients are tasked with collecting specimens at home, the procedure can require special timing, collection steps, or storage conditions. If these aren’t clearly communicated to the patient beforehand, it can lead to confusion and...

Creative approaches to laboratory outreach staffing - Insights

In a constrained staffing environment, how can an outreach program effectively meet customer needs? Through creativity, collaboration, and shared services, there can be multiple solutions to provide the support needed by the laboratory...

Christmas Specimen Shipping Guidelines and Schedule - Insights

Due to the Christmas holiday (recognized on Wednesday, Dec. 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen stability and prevent delays, follow the guidelines outlined below for...

Operational updates - Insights

The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.

News - Insights

As a global reference laboratory integrated with a world-renowned academic health care institution, Mayo Clinic Laboratories helps providers advance patient care, strengthen your practice, and broaden access to specialized testing. Follow...

Independence Day Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming July 4th holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and...

Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics - Insights

Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...

Mayo Clinic-developed mass spectrometry assay improves detection of monoclonal proteins, advancing outcomes in hard-to-treat diseases - Insights

The assay is now recommended for diagnosing and monitoring patients with monoclonal protein disorders and exclusively available through Mayo Clinic Laboratories– Rochester.

5 Tips for Effectively Surveying Lab Customers - Insights

Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.

Three core elements of exceptional customer service - Insights

Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.

Respiratory viruses - Insights

Browse our full suite of serology and PCR testing for respiratory viruses like influenza, RSV, and more.

Dietrich Matern, M.D., Ph.D., Elected to American College of Medical Genetics and Genomics Board - Insights

Dietrich Matern, M.D., Ph.D., Division Chair of Laboratory Genetics in the Department of Laboratory Medicine and Pathology in Rochester, Minnesota, has been appointed as a new director on the board of the American College of Medical...

Five Steps to Optimizing Your Outreach Test Menu - Insights

With changes in technology, medical practice, and market trends, and the expansion of health system services, the laboratory test menu can be ever in flux. It is essential that the laboratory test menu keeps up with trends, remaining...

Is the term "outreach" obsolete? - Insights

In a competitive outpatient testing market, choosing a laboratory is discretionary. With the goal of becoming the laboratory of choice for discretionary outpatient testing, it no longer matters if it is called “inreach” or “outreach.” While...

Preparing a customer performance update report - Insights

Depending on the types of specimens that are referred to the outreach laboratory, there may be an opportunity to share a customer performance update report with the client so that they can align with, or even develop their own laboratory...

Managing Compliance in Preparation for 2025 Updates - Insights

With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans.

Lysosomal Storage Disease Panel by NGS [Test in Focus] - Insights

Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow...

Solutions for Common Service Recovery Challenges - Insights

Despite our best efforts, customer service failures do happen, but good service recovery tools can turn failures into positive customer experiences.

numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology - Insights

numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance...

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. - Insights

Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune...

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP - Insights

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in...

Oncology - Insights

Learn more about our pediatric oncology testing, which was carefully developed by a team of experts to provide efficient, actionable answers.

Endocrinology Testing - Mayo Clinic Laboratories

Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing.

Muscle and nerve biopsy consultation - Insights

Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.

Neuropathies - Mayo Clinic Laboratories

Our comprehensive approach evaluates specific antibodies associated with autoimmune or paraneoplastic neuropathies offering answers for patients.

Pulmonary Pathology

Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.

Research collaborations - Insights

Find out about setting up a contract with Mayo Clinic, analytical validation, the role of the institutional review board, and how your data will be handled.

Invasive fungal infection - Insights

Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.

Histoplasma/Blastomyces - Insights

Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.

B-cell and T-cell acute lymphoblastic leukemia - Insights

Find out how our suite of B-cell and T-cell acute lymphoblastic leukemia tests can detect genetic subgroups and assist in treatment selection.

Next-generation sequencing - Insights

Browse our comprehensive next-generation sequencing test menu for patients who have bleeding and thrombosis disorders.

VEXAS syndrome - Insights

Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.

Stimulants - Insights

Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.

Chain of custody drug testing - Insights

Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.

Comprehensive drug urine profiles - Insights

Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.

Urine supersaturation testing - Insights

Find out how our kidney stone testing services can predict the likely composition of stones in patients for whom stone analysis is not available.

Hereditary causes of kidney stones - Insights

Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.

Ova and parasite testing - Insights

Learn about our ova and parasite test and its role as a fundamental laboratory method to detect parasitic helminths and protozoa in stool specimens.

Comprehensive urine drug profiles - Insights

Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.

Confirmatory testing - Insights

Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.

Colorectal Cancer NGS Testing - Mayo Clinic Laboratories

Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.

Acute Myeloid Leukemia Testing - Mayo Clinic Laboratories

Find out how our clinically validated testing for acute myeloid leukemia can provide critical diagnostic, prognostic, and therapeutic information for physicians.

Testing Archives - Page 22 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) - Insights

Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV....

Staphylococcus species assay [Test in Focus] - Insights

Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing...

Testing Archives - Page 9 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 10 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Zooming in on Cancer Suspects - Insights

Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the "culprit" might be a rearrangement in a person's DNA, which genomic testing can capture. Mayo...

Testing Archives - Page 20 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Neuro-Oncology Testing - Mayo Clinic Laboratories

At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient